umu.sePublications
Change search
Link to record
Permanent link

Direct link
BETA
Lagerqvist, Carina
Publications (8 of 8) Show all publications
Uijterschout, L., Domellöf, M., Berglund, S. K., Abbink, M., Vos, P., Rövekamp, L., . . . Brus, F. (2016). Serum hepcidin in infants born after 32 to 37 wk of gestational age. Pediatric Research, 79(4), 608-613
Open this publication in new window or tab >>Serum hepcidin in infants born after 32 to 37 wk of gestational age
Show others...
2016 (English)In: Pediatric Research, ISSN 0031-3998, E-ISSN 1530-0447, Vol. 79, no 4, p. 608-613Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Preterm infants are at risk of iron deficiency (ID). Hepcidin has been suggested as a good additional indicator of ID in preterm infants, next to ferritin.

METHODS: In a prospective observational study, we analyzed serum hepcidin in 111 infants born after 32+0 to 36+6 wk gestational age during the first 4 mo of life.

RESULTS: Hepcidin concentrations decreased during the first 4 mo of life, and concentrations were lower in infants with ID compared to those without ID. Infants who developed ID at the age of 4 mo had already significantly lower levels of hepcidin at 1.5 mo of age, while ferritin was already significantly lower at the age of 1 wk.

CONCLUSION: Hepcidin concentrations of late preterm infants decrease during the first 4 mo of life. This decrease, which parallels a decrease of ferritin concentration, we interpret as a physiological response, aiming to increase iron availability. Hepcidin concentrations are lower in infants with ID compared with those without ID, with a notable change already observed at 1.5 mo of age. Hepcidin can be used as an early marker of ID, although an additive value of hepcidin over ferritin in the diagnosis of ID is not present.

National Category
Pediatrics
Identifiers
urn:nbn:se:umu:diva-118650 (URN)10.1038/pr.2015.258 (DOI)000374380400014 ()26672736 (PubMedID)
Available from: 2016-03-29 Created: 2016-03-29 Last updated: 2018-06-07Bibliographically approved
Webb, C., Norström, F., Myléus, A., Ivarsson, A., Halvarsson, B., Högberg, L., . . . Carlsson, A. (2015). Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. Journal of Pediatric Gastroenterology and Nutrition - JPGN, 60(6), 787-791
Open this publication in new window or tab >>Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening
Show others...
2015 (English)In: Journal of Pediatric Gastroenterology and Nutrition - JPGN, ISSN 0277-2116, E-ISSN 1536-4801, Vol. 60, no 6, p. 787-791Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES: To evaluate any potential correlation between anti-tissue transglutaminase antibodies of type immunoglobulin A (tTG-IgA) and the degree of gluten induced enteropathy in children participating in a screening study for celiac disease (CD) and to assess to what extent the revised ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition) guidelines cover this group of patients.

METHODS: This is a sub-study of a cross-sectional CD screening study, ETICS (Exploring the Iceberg of Celiacs in Sweden), a two-phased study performed during 2005-2006 and 2009-2010. The 13,279 participating children had a blood test obtained and those with positive tTG-IgA were recommended a small intestinal biopsy. The tTG-IgA levels at the time of biopsy were compared with the assessment of the biopsy.

RESULTS: There were 267 children included, of whom 230 were diagnosed with CD. Out of all children, 67 children had low tTG-IgA levels (<5 U/mL), whereof 55% had Marsh 3 lesions. All children with tTG-IgA levels exceeding 10 times the upper limit of normal values of 5 U/mL, i.e. 50 U/mL, were diagnosed with CD. Lowering the cut-off to 3 U/mL, all but one child with 30 U/mL got CD diagnosis.

CONCLUSION: By adapting the revised ESPGHAN criteria, biopsies could have been omitted in a fourth of all cases. Our results indicate, that the criteria might be useful even on screened children. Further studies are needed to confirm whether the 2012 ESPGHAN guidelines should be revised to also apply to the populations being screened.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2015
Keywords
celiac disease, diagnosis, enteropathy, screening, serological markers
National Category
Gastroenterology and Hepatology Pediatrics Nutrition and Dietetics
Identifiers
urn:nbn:se:umu:diva-97984 (URN)10.1097/MPG.0000000000000688 (DOI)000355242100016 ()25564816 (PubMedID)
Available from: 2015-01-12 Created: 2015-01-12 Last updated: 2018-06-07Bibliographically approved
Webb, C., Myléus, A., Norström, F., Hammarroth, S., Högberg, L., Lagerqvist, C., . . . Carlsson, A. (2015). High adherence to a gluten-free diet in adolescents with screening-detected celiac disease. Journal of Pediatric Gastroenterology and Nutrition - JPGN, 60(1), 54-59
Open this publication in new window or tab >>High adherence to a gluten-free diet in adolescents with screening-detected celiac disease
Show others...
2015 (English)In: Journal of Pediatric Gastroenterology and Nutrition - JPGN, ISSN 0277-2116, E-ISSN 1536-4801, Vol. 60, no 1, p. 54-59Article in journal (Refereed) Published
Abstract [en]

OBJECTIVES: To evaluate the gluten-free diet (GFD) adherenceafter one year of follow-up in children with screening-detected celiac disease (CD) in a general population. METHODS: A total of 18,325 12 year olds were invited to participate in apopulation-based CD screening (ETICS- Exploring the Iceberg of Celiacs in Sweden), of whom 13,279 participated. In 240 children, CD was detected through elevated anti-tissue transglutaminase antibodies 2 (TG2-IgA) and verified by a small-intestinal biopsy. This sub-study included the 210 children with TG2-IgAevaluated both at the initialbiopsy occasion and at the one-year follow-up. GFD adherence was evaluated by a combination of TG2-IgA measurements and self-reported adherence (n = 193). RESULTS: After one year, 83% (179/210) had normalizedTG2-IgA levels (<5U/mL). Among those who had >50 U/mL at diagnosis,25% (16/63) still had elevated TG2-IgA but for the majority their initial values were more than halved. Most reported a high level ofGFD adherence ('always' 75%(158/193) and 'often' 14%(30/193)), and 75% (145/193) reported always adhereingcombined with normalized TG2-IgA. Although reporting that they were always adherent, 13 (6.7%) had not yet normalized their TG2-IgA levels completely, however, a majority of these initially had the highestTG2-IgA levels. CONCLUSIONS: GFD adherence is high in adolescents with CD detected by screening of the general population of Swedish 12yearolds. Almost all had normalized serology and reported GFD adherenceat the one-year follow-up. However, a few adolescents whoreported GFD adherence still had elevated TG2-IgA levelssuggesting more severe disease and/or non-adherence.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2015
Keywords
adolescents, anti-tissue transglutaminase antibodies, celiac disease, gluten-free diet, screening
National Category
Pediatrics Public Health, Global Health, Social Medicine and Epidemiology Gastroenterology and Hepatology Nutrition and Dietetics
Identifiers
urn:nbn:se:umu:diva-93535 (URN)10.1097/MPG.0000000000000571 (DOI)000348460100017 ()25238121 (PubMedID)
Available from: 2014-09-24 Created: 2014-09-24 Last updated: 2018-06-07Bibliographically approved
Uljterschout, L., Swinkels, D. W., Domellöf, M., Lagerqvist, C., Hudig, C., Tjalsma, H., . . . Brus, F. (2014). Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5-3 y. Pediatric Research, 76(4), 409-414
Open this publication in new window or tab >>Serum hepcidin measured by immunochemical and mass-spectrometric methods and their correlation with iron status indicators in healthy children aged 0.5-3 y
Show others...
2014 (English)In: Pediatric Research, ISSN 0031-3998, E-ISSN 1530-0447, Vol. 76, no 4, p. 409-414Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: The diagnostic use of hepcidin is limited by the absence of standardization and lack of age-specific reference ranges in children in particular. The aim of this study was to determine reference ranges of serum hepcidin in healthy children aged 0.5-3 y using mass spectometry (MS) and a commercial immunochemical (IC) assay, and to investigate its association with other indicators of iron status and inflammation. METHODS: We included 400 healthy children aged 0.5-3 y. We constructed reference ranges for MS-hepcidin and IC-hepcidin concentrations using the median, P2.5, and P97.5 in a normative population of 219 children with no anemia, no infection and/or inflammation, and no iron deficiency. RESULTS: Median concentrations (P2.5-P97.5) of MS-hepcidin and IC-hepcidin were 3.6 nmol/l (0.6-13.9 nmol/l) and 7.9 nmol/l (1.9-28.6 nmol/l), respectively. We found a good correlation between both methods. However, MS-hepcidin was consistently lower than IC-hepcidin. Hepcidin correlated with ferritin and C-reactive protein. CONCLUSION: We provide reference ranges for hepcidin for an MS and commercial IC method. Absolute values between assays differed significantly, but hepcidin concentrations obtained by MS and IC methods correlate with each other, and both correlate with ferritin and CRP.

Place, publisher, year, edition, pages
Nature Publishing Group, 2014
National Category
Pediatrics
Identifiers
urn:nbn:se:umu:diva-95270 (URN)10.1038/pr.2014.109 (DOI)000342332000012 ()
Available from: 2014-11-04 Created: 2014-10-27 Last updated: 2018-06-07Bibliographically approved
Sandström, O., Rosén, A., Lagerqvist, C., Carlsson, A., Hernell, O., Högberg, L. & Ivarsson, A. (2013). Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in a sequential testing. Journal of Pediatric Gastroenterology and Nutrition - JPGN, 57(4), 472-476
Open this publication in new window or tab >>Transglutaminase IgA antibodies in a celiac disease mass screening and the role of HLA-DQ genotyping and endomysial antibodies in a sequential testing
Show others...
2013 (English)In: Journal of Pediatric Gastroenterology and Nutrition - JPGN, ISSN 0277-2116, E-ISSN 1536-4801, Vol. 57, no 4, p. 472-476Article in journal (Refereed) Published
Abstract [en]

Objectives: The aim of this study was to evaluate hypothetical screening strategies in a Swedish celiac disease (CD) mass screening.

Methods: Of 10,041 Swedish sixth graders born in 1993 invited to a population-based CD mass screening, 7208 participated. Anti-tissue transglutaminase (tTG) immunoglobulin (Ig) A were analyzed in all children and total serum IgA (s-IgA) in 7161 children. Additional analyses of tTG-IgG, endomysial antibodies (EMA) IgA and IgG, and human leukocyte antigen (HLA) alleles were performed according to a standardized protocol. Children with elevated levels of serological markers were recommended to undergo a small intestinal biopsy to verify diagnosis, and 153 children with CD were thus identified. Sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs) were calculated and receiver operating characteristic curves were plotted.

Results: By lowering the cutoff for tTG-IgA, 17 additional cases of CD were identified at the cost of 32 biopsies. All children with tTG-IgA >50 U/mL (10 times the recommended upper limit of normal) had gluten enteropathy. Area under the receiver operating characteristic curve for tTG-IgA was 0.988. All cases carried HLA-DQ2 or HLA-DQ8, as did 53% of the controls. For different hypothetical screening strategies, sensitivity, specificity, PPV, and NPV ranged between 87.6% and 100%, 99.5% and 99.9%, 79.7% and 89.7%, and 99.7% and 100%, respectively. Efforts to increase sensitivity by lowering tTG-IgA cutoff would result in increased number of small intestinal biopsies and lower PPV. Sequential testing for both EMA and HLA-DQ genotyping would reduce the number of negative small intestinal biopsies.

Conclusions: tTG-IgA is a robust marker when used in CD mass screening and its performance can be enhanced by sequential testing for EMA or HLA-DQ genotyping.

Place, publisher, year, edition, pages
Lippincott Williams & Wilkins, 2013
Keywords
celiac disease, mass screening, transglutaminase antibodies, HLA-DQ2 and DQ8
National Category
Public Health, Global Health, Social Medicine and Epidemiology Gastroenterology and Hepatology Nutrition and Dietetics Pediatrics
Identifiers
urn:nbn:se:umu:diva-60845 (URN)10.1097/MPG.0b013e31829ef65d (DOI)000326745500020 ()23783015 (PubMedID)
Funder
Swedish Research Council, 521 2004 7093, 521 2007 2953Swedish Research Council Formas, 222-2004-1918, 222-2007-1394EU, European Research Council, FP6-2005-FOOD-4B-36383-PREVENTCD
Available from: 2012-10-31 Created: 2012-10-31 Last updated: 2018-06-08Bibliographically approved
Myléus, A., Ivarsson, A., Webb, C., Danielsson, L., Hernell, O., Högberg, L., . . . Carlsson, A. (2009). Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. Journal of Pediatric Gastroenterology and Nutrition - JPGN, 49(2), 170-176
Open this publication in new window or tab >>Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic
Show others...
2009 (English)In: Journal of Pediatric Gastroenterology and Nutrition - JPGN, ISSN 0277-2116, E-ISSN 1536-4801, Vol. 49, no 2, p. 170-176Article in journal (Refereed) Published
Abstract [en]

Objetive: Sweden experienced a marked epidemic of celiac disease between 1984 and 1996 in children younger than 2 years of age, partly explained by changes in infant feeding. The objective of this study was to determine the prevalence of celiac disease in 12-year-olds born during the epidemic (1993), including both symptomatic and screening detected cases.

Patients and methods: All sixth-grade children in participating schools were invited (n = 10,041). Symptomatic and, therefore, previously diagnosed celiac disease cases were ascertained through the National Swedish Childhood Celiac Disease Register and/or medical records. All serum samples were analyzed for antihuman tissue transglutaminase (tTG)-IgA (Celikey), and serum-IgA, and some for tTG-IgG and endomysial antibodies. A small intestinal biopsy was recommended for all children with suspected undiagnosed celiac disease.

Results: Participation was accepted by 7567 families (75%). Previously diagnosed celiac disease was found in 67 children; 8.9/1000 (95% confidence interval [CI] 6.7-11). In another 192 children, a small intestinal biopsy was recommended and was performed in 180. Celiac disease was verified in 145 children, 20/1000 (95% CI 17-23). The total prevalence was 29/1000 (95% CI 25-33).

Conclusions: The celiac disease prevalence of 29/1000 (3%)-with two thirds of cases undiagnosed before screening-is 3-fold higher than the usually suggested prevalence of 1%. When these 12-year-olds were infants, the prevailing feeding practice was to introduce gluten abruptly, often without ongoing breast-feeding, which might have contributed to this unexpectedly high prevalence.

Place, publisher, year, edition, pages
New York: Raven P, 2009
Keywords
Celiac disease, Children, Infant nutrition, Prevalence, Screening
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
urn:nbn:se:umu:diva-25334 (URN)10.1097/MPG.0b013e31818c52cc (DOI)19516192 (PubMedID)
Available from: 2009-08-12 Created: 2009-08-12 Last updated: 2018-06-08Bibliographically approved
Lagerqvist, C., Dahlbom, I., Hansson, T., Jidell, E., Juto, P., Olcén, P., . . . Ivarsson, A. (2008). Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age.. J Pediatr Gastroenterol Nutr, 47(5), 428-35
Open this publication in new window or tab >>Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age.
Show others...
2008 (English)In: J Pediatr Gastroenterol Nutr, ISSN 1536-4801, Vol. 47, no 5, p. 428-35Article in journal (Other academic) Published
Identifiers
urn:nbn:se:umu:diva-10741 (URN)18852634 (PubMedID)
Available from: 2008-10-29 Created: 2008-10-29 Last updated: 2018-06-09Bibliographically approved
Andersson, Y., Lindquist, S., Lagerqvist, C. & Hernell, O. (2000). Lactoferrin is responsible for the fungistatic effect of human milk.. Early Human Development, 59(2), 95-105
Open this publication in new window or tab >>Lactoferrin is responsible for the fungistatic effect of human milk.
2000 (English)In: Early Human Development, ISSN 0378-3782, E-ISSN 1872-6232, Vol. 59, no 2, p. 95-105Article in journal (Refereed) Published
Abstract [en]

Human milk has recognized anti-microbial effects and it has been repeatedly shown that breast-fed infants have fewer and less severe infections than formula-fed infants. While most studies have focused on anti-bacterial and anti-viral activities few have focused on the anti-fungal effect of human milk. Dermal and other infections caused by fungi are common in very low birth weight (VLBW) infants. Using a liquid culturing method and Candida albicans and Rhodotorula rubra as representative fungi, we studied the anti-fungal effect of human milk and certain human milk proteins. In vitro, human milk showed potent inhibitory effect on fungal growth. Most, if not all of this effect was caused by lactoferrin via its iron-binding capacity; increasing the iron content of the incubation medium abolished the inhibitory effect. In contrast, other human milk proteins with known or suggested anti-microbial effects rather increased fungal growth. Viability test and electron microscopy revealed that the growth inhibitory effect of human milk, i.e. mediated by lactoferrin, is fungistatic rather than fungicidal.

Identifiers
urn:nbn:se:umu:diva-54222 (URN)10996747 (PubMedID)
Available from: 2012-04-19 Created: 2012-04-19 Last updated: 2018-06-08
Organisations

Search in DiVA

Show all publications